Robarts Clinical Trials Inc. & Western University
agree to new ownership structure
London, Ontario, CANADA, 1-February-2018 – Robarts Clinical Trials Inc. announced today that it has entered into an agreement with Western University’s Robarts Research Institute at the Schulich School of Medicine and Dentistry, to spin off Robarts Clinical Trials Inc. (RCTI). RCTI will operate independently under a unique, social enterprise structure that will engage in the development, support and promotion of human health.
As a specialized global research organization, RCTI will remain focused on its vision to be recognized as an industry leader in delivering high value research and randomized clinical trials that assess issues of importance to human health. RCTI will continue to operate under its current name as it seeks to expand its position in the competitive contract research industry.
“We are extremely proud that Robarts Clinical Trials was founded at Western and has developed into a leading, international organization in its field. It is a natural next step for Robarts Clinical Trials to become its own entity, demonstrating the strong culture of innovation, entrepreneurialism and commercialization that exists at Western.” John Capone, Vice-President (Research), Western University
“This is a historic day for Western, RCTI and the community of London. Over its 30-year history as a research organization RCTI has delivered important research that has transformed human health, attracted world class researchers to London, created desirable employment opportunities and generated significant economic impact each year in the city of London. We remain committed to upholding this enduring legacy and are now well positioned to grow our organization as we continue to anticipate the needs of our valued customers as they develop new life changing therapies with the support of our services,” Jeff Smith, CEO, and Dr. Brian Feagan, Senior Scientific Director, Robarts Clinical Trials Inc.
MEDIA CONTACT: Fern Livingstone
Manager, Marketing & Communications
Tel: (519) 639 3205
About Robarts Clinical Trials Inc.
Robarts Clinical Trials Inc. is a global research organization providing clinical trial and central image management services to the pharmaceutical and biotechnology industries. Headquartered in London Ontario, RCTI employs more than 200 people across its operations in Canada, the United States, Amsterdam, Hungary, Germany and the United Kingdom. Its unique model combines the efforts of leading internationally recognized academic researchers with operational experts to offer integrated solutions to its pharmaceutical and biotechnology partners. Founded in 1986 at the Robarts Research Institute, the clinical trials division was initially lead by Dr. Henry Barnett. In 1997, Dr. Brian Feagan, Professor of Medicine, Epidemiology & Biostatistics at Western University assumed leadership and built on the foundation of academic excellence by focusing the organization towards Inflammatory Bowel Disease research. Over the past 20 years, RCTI has become recognized as the expert in clinical trial design, execution, outcome development and image management for drug development. Today, Robarts Clinical Trials Inc. provides services in over 50 countries worldwide, collaborates with leading academic research institutions across the globe and partners with many of the leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients.
About Western University
Western University delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
# # #